由DNA疫苗诱导的HIV-1特异性细胞介导的免疫反应通过甘露糖包被的脂质体得到增强，并被抗干扰素-γ抗体抑制。
HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody.
作者信息
Toda S, Ishii N, Okada E, Kusakabe K I, Arai H, Hamajima K, Gorai I, Nishioka K, Okuda K
机构信息
Department of Bacteriology, Yokohama City University School of Medicine, Japan.
出版信息
Immunology. 1997 Sep;92(1):111-7. doi: 10.1046/j.1365-2567.1997.00307.x.
Abstract
The adjuvant effect of mannan-coated liposomes on human immunodeficiency virus type-1 (HIV-1) DNA vaccine and the mechanism of this enhancement were studied. Coating of cationic liposomes with mannan significantly enhanced the ability of this vaccine to induce an HIV-specific delayed-type hypersensitivity (DTH) response. HIV-specific cytotoxic T-cell (CTL) activity elicited by DNA vaccination was also significantly enhanced with the mannan-liposome cocktail. This mannan-liposome-mediated activity was greatly inhibited by in vivo injection of anti-interferon (IFN)-gamma antibody, which suggests that IFN-gamma plays an important role in this HIV-specific immune response. The results of both isotype-specific antibody and cytokine analysis revealed that mannan-liposome-mediated DNA vaccination enhances Th1-mediated immunity.
摘要
研究了甘露聚糖包被的脂质体对1型人类免疫缺陷病毒（HIV-1）DNA疫苗的佐剂作用及其增强机制。用甘露聚糖包被阳离子脂质体可显著增强该疫苗诱导HIV特异性迟发型超敏反应（DTH）的能力。甘露聚糖-脂质体混合物也显著增强了DNA疫苗引发的HIV特异性细胞毒性T细胞（CTL）活性。体内注射抗干扰素（IFN）-γ抗体可大大抑制这种甘露聚糖-脂质体介导的活性，这表明IFN-γ在这种HIV特异性免疫反应中起重要作用。同型特异性抗体和细胞因子分析结果均显示，甘露聚糖-脂质体介导的DNA疫苗接种可增强Th1介导的免疫。
相似文献
1
HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody.由DNA疫苗诱导的HIV-1特异性细胞介导的免疫反应通过甘露糖包被的脂质体得到增强，并被抗干扰素-γ抗体抑制。
Immunology. 1997 Sep;92(1):111-7. doi: 10.1046/j.1365-2567.1997.00307.x.
2
Human immunodeficiency virus type-1-specific immune responses induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine.甘露聚糖包被的二C14-脒可极大增强DNA疫苗诱导的1型人类免疫缺陷病毒特异性免疫反应。
Eur J Immunol. 1997 Dec;27(12):3121-9. doi: 10.1002/eji.1830271207.
3
Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system.酵母聚糖通过激活补体系统增强对1型人类免疫缺陷病毒DNA疫苗的免疫反应。
Immunology. 2001 May;103(1):98-105. doi: 10.1046/j.1365-2567.2001.01201.x.
4
HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine.通过将TCA3表达质粒与DNA疫苗共同接种可增强HIV-1特异性细胞介导的免疫。
Immunology. 1997 Jan;90(1):1-6. doi: 10.1046/j.1365-2567.1997.00117.x.
5
Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.增强重组痘苗病毒天坛株（MVA）免疫反应：利用表达Env以及细胞因子白细胞介素-12（IL-12）和干扰素-γ（IFN-γ）的MVA和DNA载体增强对HIV-1的免疫反应。
Virus Res. 2006 Mar;116(1-2):11-20. doi: 10.1016/j.virusres.2005.08.008. Epub 2005 Oct 7.
6
IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine.白细胞介素-15表达质粒增强了由HIV-1 DNA疫苗诱导的细胞介导免疫。
Vaccine. 1999 Feb 26;17(7-8):858-66. doi: 10.1016/s0264-410x(98)00271-0.
7
Enhanced non-inflammasome mediated immune responses by mannosylated zwitterionic-based cationic liposomes for HIV DNA vaccines.甘露糖基化两性离子型阳离子脂质体增强HIV DNA疫苗的非炎性小体介导的免疫反应
Biomaterials. 2016 Apr;85:1-17. doi: 10.1016/j.biomaterials.2016.01.054. Epub 2016 Jan 29.
8
Immunoliposomes containing antibodies to costimulatory molecules as adjuvants for HIV subunit vaccines.
AIDS Res Hum Retroviruses. 1998 Mar 20;14(5):409-17. doi: 10.1089/aid.1998.14.409.
9
Intranasal administration of HIV-DNA vaccine formulated with a polymer, carboxymethylcellulose, augments mucosal antibody production and cell-mediated immune response.用聚合物羧甲基纤维素配制的HIV-DNA疫苗经鼻内给药可增强粘膜抗体产生和细胞介导的免疫反应。
Clin Immunol Immunopathol. 1998 Aug;88(2):205-10. doi: 10.1006/clin.1998.4566.
10
Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1.阳离子脂质体是1型人类免疫缺陷病毒DNA疫苗的强效佐剂。
AIDS Res Hum Retroviruses. 1997 Nov 1;13(16):1421-8. doi: 10.1089/aid.1997.13.1421.
引用本文的文献
1
Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caused COVID-19 and other viral diseases.用于预防和治疗由 SARS-CoV-2 引起的 COVID-19 和其他病毒疾病的抗病毒多糖和抗病毒肽递送纳米材料。
J Control Release. 2023 Jun;358:476-497. doi: 10.1016/j.jconrel.2023.05.010. Epub 2023 May 14.
2
Liposomal Formulations of a Polyleucine-Antigen Conjugate as Therapeutic Vaccines against Cervical Cancer.一种聚亮氨酸-抗原偶联物的脂质体制剂作为抗宫颈癌治疗性疫苗
Pharmaceutics. 2023 Feb 10;15(2):602. doi: 10.3390/pharmaceutics15020602.
3
Mannose-Modified Chitosan-Nanoparticle-Based Subunit OralVaccine-Induced Immune Response and Efficacy in a Challenge Trial in Broilers.基于甘露糖修饰壳聚糖纳米颗粒的亚单位口服疫苗在肉鸡攻毒试验中的免疫应答及效果
Vaccines (Basel). 2020 Jun 11;8(2):299. doi: 10.3390/vaccines8020299.
4
Biodegradable polymers for modern vaccine development.用于现代疫苗开发的可生物降解聚合物。
J Ind Eng Chem. 2019 Sep 25;77:12-24. doi: 10.1016/j.jiec.2019.04.044. Epub 2019 Apr 28.
5
Nanomedicine Strategies to Target Tumor-Associated Macrophages.靶向肿瘤相关巨噬细胞的纳米医学策略
Int J Mol Sci. 2017 May 4;18(5):979. doi: 10.3390/ijms18050979.
6
Yeast Surface Display of Two Proteins Previously Shown to Be Protective Against White Spot Syndrome Virus (WSSV) in Shrimp.酵母表面展示两种先前已证明对虾的白斑综合征病毒（WSSV）具有保护作用的蛋白质。
PLoS One. 2015 Jun 17;10(6):e0128764. doi: 10.1371/journal.pone.0128764. eCollection 2015.
7
Dendritic cell immunotherapy: clinical outcomes.树突状细胞免疫疗法：临床结果。
Clin Transl Immunology. 2014 Jul 18;3(7):e21. doi: 10.1038/cti.2014.14. eCollection 2014 Jul.
8
Modulation of HIV-1 immunity by adjuvants.佐剂对 HIV-1 免疫的调节。
Curr Opin HIV AIDS. 2014 May;9(3):242-9. doi: 10.1097/COH.0000000000000052.
9
Targeting antigens to dendritic cell receptors for vaccine development.将抗原靶向树突状细胞受体用于疫苗开发。
J Drug Deliv. 2013;2013:869718. doi: 10.1155/2013/869718. Epub 2013 Oct 8.
10
A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.纳米技术在预防 HIV/AIDS 中的应用综述。
Biomaterials. 2013 Aug;34(26):6202-28. doi: 10.1016/j.biomaterials.2013.05.012. Epub 2013 May 28.
本文引用的文献
1
2
Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes.白细胞介素-12介导小鼠对克氏锥虫的抗性，并由小鼠巨噬细胞在响应活的锥鞭毛体时产生。
Infect Immun. 1996 Jun;64(6):1961-7. doi: 10.1128/iai.64.6.1961-1967.1996.
3
Protective immunity against HIV infection: has nature done the experiment for us?针对HIV感染的保护性免疫：大自然已经为我们完成这个实验了吗？
Immunol Today. 1996 Jan;17(1):21-4. doi: 10.1016/0167-5699(96)80564-0.
4
IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses.白细胞介素-12缺陷型小鼠在γ干扰素产生和1型细胞因子反应方面存在缺陷。
Immunity. 1996 May;4(5):471-81. doi: 10.1016/s1074-7613(00)80413-6.
5
DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein.小鼠中的DNA介导免疫诱导出针对乙肝表面抗原蛋白的强大的主要组织相容性复合体I类分子限制性细胞毒性T淋巴细胞反应。
Hum Gene Ther. 1995 Nov;6(11):1447-56. doi: 10.1089/hum.1995.6.11-1447.
6
Interleukin 12 in combination with anti-interleukin 10 reverses graft prolongation after portal venous immunization.
Transplantation. 1995 Dec 15;60(11):1337-41.
7
IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells.白细胞介素-12可诱导新生儿人类CD4 T细胞产生γ干扰素。
J Immunol. 1993 Aug 15;151(4):1938-49.
8
A strategy for prophylactic vaccination against HIV.一种针对艾滋病毒的预防性疫苗接种策略。
Science. 1993 May 28;260(5112):1270-2. doi: 10.1126/science.8098553.
9
Individual cells simultaneously produce both IL-4 and IL-6 in vivo.在体内，单个细胞可同时产生白细胞介素-4和白细胞介素-6。
Cytokine. 1994 May;6(3):329-36. doi: 10.1016/1043-4666(94)90030-2.
Zotero 插件